Intellectual Property (Details Narrative)
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
|
Oct. 27, 2014
USD ($)
|
Aug. 31, 2017
USD ($)
|
Aug. 31, 2016
USD ($)
|
Aug. 31, 2017
USD ($)
|
Aug. 31, 2017
CAD
|
Aug. 31, 2016
USD ($)
|
| Amortization expense | $ |
|
$ 15,895
|
$ 9,532
|
$ 31,789
|
|
$ 31,789
|
| Royalty payments payable | CAD |
|
|
|
|
CAD 25,700,000
|
|
| Intellectual property agreement [Member] | Mr. Hatem Essaddam [Member] |
|
|
|
|
|
|
| Purchase price of certain technique and method under agreement | $ |
$ 445,050
|
|
|
|
|
|
| Description of milestone payments |
| |
(i) |
CDN$200,000
when an average of twenty (20) metric tons per day of terephthalic acid is produced by the Company for twenty (20) operating
days; |
| |
|
|
| |
(ii) |
CDN$200,000
when an average of thirty (30) metric tons per day of terephthalic acid is produced by the Company for thirty (30) operating
days; |
| |
|
|
| |
(iii) |
CDN$200,000
when an average of sixty (60) metric tons per day of terephthalic acid is produced by the Company for sixty (60) operating
days; and |
| |
|
|
| |
(iv) |
CDN$200,000
when an average of one hundred (100) metric tons per day of terephthalic acid is produced by the Company for sixty (60) operating
days. |
|
|
|
|
|
|
| Description of royalty payments |
|
|
|
| |
(a) |
10%
of gross profits on the sale of all products derived by the Company from the technology assigned to the Company under the
agreement; |
| |
|
|
| |
(b) |
10%
of any license fee paid to the Company in respect of any licensing or other right to use the technology assigned to the Company
and granted to a third party by the Assignee; |
| |
|
|
| |
(c) |
5%
of any royalty or other similar payment made to the Company by a third party to whom a license or other right to use the technology
assigned to the Company has been granted by the Company; and |
| |
|
|
| |
(d) |
5%
of any royalty or other similar payment made to the Company by a third party in respect of a sub-license or other right to
use the technology assigned to the Company granted by the third party. |
|
| |
(a) |
10%
of gross profits on the sale of all products derived by the Company from the technology assigned to the Company under the
agreement; |
| |
|
|
| |
(b) |
10%
of any license fee paid to the Company in respect of any licensing or other right to use the technology assigned to the Company
and granted to a third party by the Assignee; |
| |
|
|
| |
(c) |
5%
of any royalty or other similar payment made to the Company by a third party to whom a license or other right to use the technology
assigned to the Company has been granted by the Company; and |
| |
|
|
| |
(d) |
5%
of any royalty or other similar payment made to the Company by a third party in respect of a sub-license or other right to
use the technology assigned to the Company granted by the third party. |
|
|
| Additional payments under agreement | CAD |
|
|
|
|
CAD 800,000
|
|
| Intellectual property agreement [Member] | Mr. Hatem Essaddam [Member] | Patents [Member] |
|
|
|
|
|
|
| Estimated Useful Life (Years) |
7 years
|
|
|
|
|
|